A. Properties
- Highly contagious, pruritic Dermatosis
- Caused by the mite Sarcoptes scabei (variety hominus)
- An obligate human parasite; only females burrow into the skin
- Mites cannot fly or jump; they crawl ~2.5cm/minute on warm skin
- Common in children, long-term elderly and chronic care facility, homeless persons
- Norwegian Scabies is a subtype and occurs in institutionalized adults
- Increased incidence and severity in HTLV-1 and HIV infection
- Usually begins on hands, interdiginous regions
- About 300 million cases worldwide per year
B. Appearance
- Intensely pruritic eruption, usually generized
- Usually found in interdigital spaces of the hand
- Also found in skin folds, buttocks, breasts in women, and genital areas
- Usually worse at night
- Due to inflammatory reaction to mite
- Classic Lesions is "Burrow"
- Burrow is a thread-like, wavy, gray-white fissure
- Length is several millimeters
- May have small vesicle at the end of the burrow (presence of mite)
C. Diagnosis
- History and physical exam are most helpful
- Definitive diagnosis reqiures demonstration of either
- Mites
- Mite eggs or eggshell fragments
- Mite pellets
- Obtain multiple skin scrapings from characteristic lesions
- Scrape carefully across lesions to avoid bleeding
- Examine under microscope
- Do not use potassium hydroxide, which can dissolve mite pellets
- Failure to find mites is common and does not rule out scabies
- Nonspecific inflammatory reactions in skin biopsy sample can be found
- Empirical treatment of patients with generalized itching is not recommended
- Treatment for definitive diagnosis
- Treatment for clear exposure and symptoms
- Treatment for very typical eruptions even without definitive diagnosis
D. Differential Diagnosis
- Atopic dermatitis
- Dermatitis herpetiformis
- Insect bite dermatitis
- Senile pruritus
- Many others
E. Treatment [2]
- Overview
- Multiple topical agents are available
- Lindane and permethrin are best studied topical agents
- Permethrin is superior to lindane and is the preferred topical agent in the USA
- Ivermectin, an oral antiparasitic, has been shown to have excellent activity
- Ivermectin should be considered a first-line alternative therapy
- All contacts of infected persons MUST be treated (regardless of symptoms)
- Clothes and bed linens must be decontaminated by machine washing at 60°C
- Itching may persist up to 1-2 weeks after initiation of effective therapy
- Permethrin (Elimite®)
- 5% topical cream applied once to all affected surfaces
- May be combined with ivermectin therapy in difficult cases
- Permethrin is washed off 8-12 hours after application
- Overall well tolerated, much moreso than lindane
- Lindane (Kwell®)
- 1% lindane (hexachlorocyclohexane) cream, lotion or shampoo
- Systemic absorption of agent occurs
- Great care must be taken when used on children due to this absorption
- Contraindicated in persons with seizure disorders
- In general, total body application of agent is made from neck down
- Leave cream or lotion on for 6 to 12 hours
- Other Topical Agents
- Benzyl benzoate - 10% and 25% lotions, often causes skin irritation and eczema
- Malathion - 0.5% lotion
- Sulfiram - 25% lotion
- Crotamiton - 10% cream
- Ivermectin (Stromectol®) [3]
- Single dose 200µg/kg given to Norwegian scabies patients (HIV + and - were included)
- Most patients had impressive improvement within 2 weeks of dosage, regardless of HIV
- Some patients received a second dose 2 weeks after first
- No adverse effects were noted (22 patients total; 21 complete responses)
- Also available as a 0.8% lotion, though not as effective
- Pregnancy, Lactating Women, and Infants
- Lindane and ivermectin should not be used
- Precipitated sulfur 2-10% in petrolatum recommended
- Infants can be treated with esdepallethrine or benyl benzoate with caution
- Permethrin approved for use only in babies >2 months, though may be safe in <2 months
References
- Chosidow O. 2006. NEJM. 354(16):1718
- Heukelbach J and Feldmeier H. 2006. Lancet. 367(9524):1767
- Meinking TL, Taplin D, Hermida JL, et al. 1995. NEJM. 333(1):26